Newsletter

Generalized Myasthenia Gravis
A chronic autoimmune neuromuscular disease with almost 55% of the cases diagnosed in the US in the 7MM, gMG has managed to garner the attention of several pharma companies
Generalized Myasthenia Gravis Newsletter